Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1644 1646
This examiner grants 66% of resolved cases
Katherine Ann Holtzman is an examiner in Tech Center 1600 and Art Unit 1644. She has 70 resolved cases. The allowance rate is 65.7 percent. This 65.7 percent rate indicates a fair probability of success for applicants. The interview lift is 58.3 percent. This 58.3 percent lift is very high, indicating that interviews are a powerful strategy for overcoming rejections. Practitioners should prioritize interviews to take advantage of the 58.3 percent increase in allowance probability.
The median days to allowance is 1329. This 1329-day timeline indicates a relatively long prosecution period. The 70 resolved cases provide a preliminary but useful statistical foundation for these metrics. The 65.7 percent allowance rate is higher than the 58.3 percent interview lift. This comparison highlights the major impact that direct communication can have on the outcome. The 1329-day median is a key timing factor for applicants in Art Unit 1644. These 70 cases define the examiner's current performance profile.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18703264 | BIOSYNTHETIC MONOVALENT BINDING MOLECULES WITH ENHANCED EFFECTOR FUNCTIONS | Non-Final OA | Janssen Biotech, Inc. |
| 17240609 | Materials and Methods for Treating Juvenile Idiopathic Arthritis | Non-Final OA | Janssen Biotech, Inc. |
| 18562035 | COMPOSITIONS AND METHODS FOR PRODUCING AND USING CELL-BASED IMMUNOTHERAPIES TO TARGET TUMORS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
| 18708093 | Enhancement Of CD47 Blockade Therapy With Anti-VEGF Agents | Non-Final OA | PFIZER INC. |
| 18290613 | CELL-PENETRATING DEGRADING ANTIBODY THAT PENETRATES INTO CELLS TO DEGRADE AND REMOVE TARGET PROTEIN AND USE THEREOF | Non-Final OA | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 17932739 | TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA | Non-Final OA | AMGEN RESEARCH (MUNICH) GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy